Abstract

This study investigated differences between the clinical trajectories of diabetic nephropathy and nephrosclerosis using the Kidney Disease: Improving Global Outcomes (KDIGO) heat map and the clinical characteristics between the two diseases at RRT initiation. This single-center, retrospective study enrolled 100 patients whose estimated glomerular filtration rate (eGFR) was ≥45 mL/min/1.73 m2 at their first visit and who were initiated on RRT. Fifty consecutive patients were assigned to each of the diabetic nephropathy and nephrosclerosis groups. All data for simultaneously measured eGFR and urinary albumin to creatinine ratio (UACR) were collected from first visit to RRT initiation and were plotted on the KDIGO heat map. Diabetic nephropathy was characterized by higher blood pressure and UACR and lower age, eGFR, and serum albumin levels compared with nephrosclerosis at RRT initiation. The vast majority of patients with diabetic nephropathy and eGFR < 60 mL/min/1.73 m2 had concomitant macroalbuminuria, whereas for patients with nephrosclerosis, even when eGFR was <45 mL/min/1.73 m2, many still had normoalbuminuria or microalbuminuria. The rate of decline of eGFR was significantly faster in the diabetic nephropathy group than that in the nephrosclerosis group. The clinical trajectories of diabetic nephropathy and nephrosclerosis differed markedly on the KDIGO heat map.

Highlights

  • Chronic kidney disease (CKD) progressively increases the risk of end-stage kidney disease (ESKD) and cardiovascular disease in line with its severity [1]

  • The study compared the clinical progression of the two diseases as represented by the heat map based on the prognosis of CKD by glomerular filtration rate (GFR) and albuminuria category stated in the Kidney Disease: Improving Global Outcomes (KDIGO) 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease [6]

  • There was no significant difference in heart rate, both systolic and diastolic Blood pressure (BP) was significantly higher in the diabetic nephropathy group

Read more

Summary

Introduction

Chronic kidney disease (CKD) progressively increases the risk of end-stage kidney disease (ESKD) and cardiovascular disease in line with its severity [1]. Type 2 diabetes mellitus is among the leading causes of CKD, including ESKD, in both developed and developing countries; in various countries including the USA and Japan, type 2 diabetes mellitus accounts for nearly 50% of patients on incident dialysis [2, 3]. In the USA in 2012, nephrosclerosis was the second most common primary disease after diabetic nephropathy [2], and in Japan in 2011, nephrosclerosis was the third most common primary disease (12.3%) after diabetic nephropathy and chronic glomerulonephritis [5]. Since about 2000, the rate of increase in the annual number of new dialysis patients with chronic glomerulonephritis has been negative [5].

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call